Debra L. Ellies, PhD - CEO, President & Chairman of the Board of Directors 

In 2011, Dr. Ellies co-founded OssiFi.  Prior to launching  OssiFi, Dr Ellies was at the Stowers Medical Research Institute in Kansas City, MO. While at the Stowers Institute, Dr. Ellies was a key scientist in the epochal discovery of Sclerostin as a modulator of the Wnt pathway.  Dr. Ellies was also part of the scientific team which discovered that the CCN family also functioned via Wnt signaling.  Furthermore, Ellies & Krumlauf were the first to report that Sclerostin blocking antibodies function by blocking Sclerostin action on the Wnt pathway. Before her work at Stowers, Dr. Ellies conducted basic research on the developmental significance of cell death and the involvement of the Wnt pathway during early facial bone development, isolated Dlx/Msx homeobox genes and studied their role during early facial bone development and managed a laboratory at Ottawa Civic Hospital in Ottawa, Canada.  In addition to her remarkable successes in the laboratory, Dr. Ellies co-founded the Brian Ellies Esophageal Cancer Prevention Fund, which works to educate the public and promote awareness of esophageal cancer prevention.  Dr. Ellies is the author of several international key scientific manuscripts in the area of signal transduction, and of a number of patents.  She received her Ph.D. from Guy’s Hospital London, UK, under the supervision of Prof. Andrew Lumsden, FRS; M.Sc. from University Ottawa, LOEB Research Institute under the supervision of Dr. Marc Ekker.

William S. Rosenberg, MD - Chief Medical Officer & Chairman of the Scientific Advisory Board 

Dr. Rosenberg is the co-founder and Chief Medical Officer of OssiFi.  He is an innovator in both his practice of medicine and in the development of new technologies and devices in life sciences.  Dr. Rosenberg specializes in complex spinal surgery as a neurosurgeon with Midwest Neurosurgery Associates in Kansas City.  Prior to joining his current group, he was Director of the Neurospinal Disorders Program at University of California, San Francisco and Co-Founder of the Spine Biomechanics Laboratory at University of California, Berkeley.  Dr. Rosenberg received his medical degree from Harvard Medical School and trained in neurosurgery at Massachusetts General Hospital in Boston.  In addition to his medical practice, Dr. Rosenberg has served as a consultant for a number of medical device companies in various stages of development and holds several patents for surgical devices and techniques.

Scientific Advisory Board

Dr. Sigurd Berven, M.D., is Associate Professor in Residence in the Department of Orthopedic Surgery at the University of California, San Francisco.  Dr. Berven has a strong clinical interest in spinal disorders of children and adults, in addition to pediatric and adult deformity, degenerative conditions of the spine, spinal tumors and spinal trauma.  Dr. Berven 's basic science research involves the use of cellular and molecular techniques to study biological regeneration of the spine, including intervertebral discs.  He is an invited speaker at national and international conferences.  He is a graduate of the Harvard Medical School Combined Orthopedic Residency.  After completing his residency, he was a chief resident at in pediatric orthopedic surgery at Boston Children's Hospital, and then studied as a clinical fellow at the UCSF Spinal Disorders Program.  Dr. Berven was an undergraduate at Stanford University, a graduate student at Oxford University in philosophy, politics and economics.  

Dr. Stephen Gordon, Ph.D., is President of Gordon Biomedical Consulting and has advised publically traded orthopedic companies, biotechs and medical school departments; led or founded several biotechnology companies; and managed more than $100 million in grants and contracts during his seventeen year tenure as Chief of Musculoskeletal Diseases Branch at NIAMS/NIH.  He also has designed and completed many pilot and randomized controlled clinical trials in osteoporosis, prepared successful FDA regulatory filings, wrote the Physicians Rehabilitation Guide for National Osteoporosis Foundation and made significant contributions to the field of orthopedics through his research and multidisciplinary collaborations.

Business Advisors

Enrico Picozza is a Venture Partner at HLM Venture Partners and a serial entrepreneur.  He has founded or served as a member of the startup team for several companies that address markets such as diagnostics and regenerative medicine.  In 2000 Enrico was a Founder, COO/CTO and board member for HTS Biosystems, a systems development company.  Under Enrico's stewardship HTS successfully developed and launched cutting edge products, which are now sold by GE Health Care.  Preceding HTS Enrico's entrepreneurial career started at Perkin-Elmer immediately after graduation from the University of Connecticut.  Enrico was the first member to join the newly formed Biotechnology group that was responsible for developing and commercialization of the PCR technology.  After 7 years and $120 million in sales this team became the catalyst for what is today Applera.  His involvement in the success of PCR was later recognized by the Smithsonian.  Today that product has a market value of > $5 billion dollars.  Enrico's experience includes international business, IP management, research & development, sales and marketing.  Market experience includes MDX, forensics, drug discovery, medical devices, proteomics and  emerging markets.  Presently Enrico is interim CEO to CELTHERA, a regenerative medicine company; he also serves as advisor to multiple other young companies, established companies, venture firms and academic organizations. 

Mark D. LoGuidice is Chairman and CEO of Spine Wave.  He is a 27-year veteran of the medical device field. His first 16 years were spent at United States Surgical Corp., where he rose through the sales and marketing ranks to Corporate Officer.  Mr. LoGuidice joined Sofamor Danek Group as President of U.S. Operations in 1995 and was a major contributor to the company’s growth until the $4-billion acquisition by Medtronic in 1999.  Since entering the venture world in 2000, Mr. LoGuidice has raised more than $100 million for the companies he has chaired, including DexCom, and Spine Wave.  Mr. LoGuidice holds an undergraduate degree from Colgate University, Hamilton, New York, and an MBA from Pace University, New York City.

Bruce W. Jenett is Partner and Co-Chair of the Global Life Sciences Sector at DLA Piper in East Palo Alto, California.  Mr. Jenett is a renowned life science lawyer who brings over 25 years of industry experience focused on the representation of domestic and international business and finance clients in the life sciences industry.  He received his J.D. from Georgetown University Law Center and a B.A. from Princeton.  Mr Jenett is highly experienced in equity and debt financing, licensing and distribution, strategic alliances, joint ventures, and mergers and acquisitions, as well as general counseling issues, representing both start-ups and large multinational corporations.  Among his many accomplishments, Mr. Jenett handled one of the largest ag-bio partnering deals in history, as well as one of the largest partnering deals ever done by an Irish venture capital-backed biotechnology company with a major pharmaceutical company.  A frequent speaker on corporate and finance issues to both business and attorney audiences, Mr. Jenett is also a member of the Bioethics Committee of BIO, the BayBio Board of Directors and Co-Chairs the Strategic Planning Committee of San Francisco's Biotech Advisory Council.  Chambers & Partners: America’s Leading Lawyers for Business consistently names him one of the leading business lawyers in the United States.

Jack P. Harrington has over 30 years experience leading both domestic and international operations organizations in the medical devices industry.  Recently retired as VP Strategic Operations Initiatives with DePuy Spine, Mr. Harrington's former role for 10 years was VP of Operations for J&J Orthopedics.  In this capacity, he built a team based organization that assisted in its tenfold growth in sales.  With a broad background in logistics & manufacturing, Mr. Harrington understands the needs of organizations working to support customers on a global basis. 

Web Hosting Companies